Janux Therapeutics, Inc.
Janux Therapeutics, Inc.（JANX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · JANX · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
14
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Janux Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
JANX 季度内部人买卖趋势
JANX 内幕交易卖出 · JANX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · JANX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
JANX 高管卖出股份 · JANX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 2, 2026 | Doyle Janeen Noel Chief Corp. & Bus. Dev. Ofcr | Sale | 4,059 | $57K | Form 4 |
| May 11, 2026 | Dobek Maria Vice President, Accounting | Sale | 2,038 | $29K | Form 4 |
| Feb 2, 2026 | Go William Chief Medical Officer | Award | 44,000 | — | Form 4 |
| Jan 2, 2026 | Meyer Andrew Hollman Chief Business Officer | Sale | 1,879 | $26K | Form 4 |
| Jan 2, 2026 | DiRaimondo Thomas Chief Scientific Officer | Award | 31,400 | — | Form 4 |
| Jan 2, 2026 | DiRaimondo Thomas Chief Scientific Officer | Sale | 2,505 | $34K | Form 4 |
| Jan 2, 2026 | Campbell David Alan President and CEO · Director | Award | 96,600 | — | Form 4 |
| Jan 2, 2026 | Campbell David Alan President and CEO · Director | Sale | 8,072 | $111K | Form 4 |
| Jan 2, 2026 | Winter Charles M. Chief Technical Officer | Award | 28,600 | — | Form 4 |
| Jan 2, 2026 | Winter Charles M. Chief Technical Officer | Sale | 2,401 | $33K | Form 4 |
| Jan 2, 2026 | McIver Zachariah Chief Medical Officer | Award | 29,000 | — | Form 4 |
| Jan 2, 2026 | McIver Zachariah Chief Medical Officer | Sale | 2,714 | $37K | Form 4 |
| Jan 2, 2026 | Doyle Janeen Noel Chief Corp. & Bus. Dev. Ofcr | Award | 36,000 | — | Form 4 |
| Jan 2, 2026 | Dobek Maria Vice President, Accounting | Award | 18,935 | — | Form 4 |
| Jan 2, 2026 | Dobek Maria Vice President, Accounting | Sale | 1,462 | $20K | Form 4 |
| Dec 1, 2025 | Meyer Andrew Hollman Chief Business Officer | Option | 3,333 | $35K | Form 4 |
| Dec 1, 2025 | Meyer Andrew Hollman Chief Business Officer | Sale | 2,700 | $89K | Form 4 |
| Dec 1, 2025 | Meyer Andrew Hollman Chief Business Officer | Sale | 633 | $21K | Form 4 |
| Nov 14, 2025 | Meyer Andrew Hollman Chief Business Officer | Option | 3,333 | $35K | Form 4 |
| Nov 14, 2025 | Meyer Andrew Hollman Chief Business Officer | Sale | 3,333 | $100K | Form 4 |
| Oct 28, 2025 | Meyer Andrew Hollman Chief Business Officer | Option | 6,666 | $71K | Form 4 |
| Oct 28, 2025 | Meyer Andrew Hollman Chief Business Officer | Option | 9,999 | $42K | Form 4 |
| Oct 28, 2025 | Meyer Andrew Hollman Chief Business Officer | Sale | 16,665 | $501K | Form 4 |
| Jun 11, 2025 | RA CAPITAL MANAGEMENT, L.P. Director | Award | 3,750 | — | Form 4 |
| Jun 11, 2025 | Barrett Ronald W Director | Award | 3,750 | — | Form 4 |
Doyle Janeen Noel
Chief Corp. & Bus. Dev. Ofcr
日期
Jun 2
股数
4,059
均价
$14.03
总金额
$57K
Campbell David Alan
President and CEO · Director
日期
Jan 2
股数
8,072
均价
$13.73
总金额
$111K
Meyer Andrew Hollman
Chief Business Officer
日期
Nov 14
股数
3,333
均价
$10.59
总金额
$35K
Meyer Andrew Hollman
Chief Business Officer
日期
Oct 28
股数
6,666
均价
$10.59
总金额
$71K
Meyer Andrew Hollman
Chief Business Officer
日期
Oct 28
股数
16,665
均价
$30.06
总金额
$501K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 JANX 内幕交易
JANX 内幕交易
Janux Therapeutics, Inc.（JANX）内幕交易数据来源于公司内部人（包括Meyer Andrew Hollman (Chief Business Officer), Dobek Maria (Vice President, Accounting), Doyle Janeen Noel (Chief Corp. & Bus. Dev. Ofcr)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。JANX内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Janux Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
JANX 内幕交易 · 5个问题Janux Therapeutics, Inc.（JANX）的内部人包括高管和董事，如Meyer Andrew Hollman (Chief Business Officer), Dobek Maria (Vice President, Accounting), Doyle Janeen Noel (Chief Corp. & Bus. Dev. Ofcr)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026